文献速递先天性心脏病外科瓣膜外科

双心室修复与Fontan术式在大动脉转位合并室间隔缺损及左室流出道梗阻患者中的比较

Biventricular repair versus Fontan completion for patients with d- or l-transposition of the great arteries with ventricular septal defect and left ventricular outflow tract obstruction.
PubMed 文献 · J Thorac Cardiovasc Surg · 2019-06-10

该研究分析了澳大利亚129例d型或l型大动脉转位合并室间隔缺损及左室流出道梗阻、具有双功能心室的患者,1990至2015年间分别接受Fontan(29例)或双心室修复(100例)。中位随访6.2年,双心室修复组死亡9例,Fontan组1例移植,无移植生存率1年95%、5年93%、10年92%、15年90%。

要点

  • 双心室修复与Fontan术后的中期生存和功能状态相当。
  • 当解剖风险因素不适合双心室修复时,Fontan是可行选择。

核心结论

  • d型或l型大动脉转位合并室间隔缺损及左室流出道梗阻患者的中期结局在Fontan与双心室修复间相当。
  • 两种路径均与优异的死亡率和功能结局相关。
  • 双心室修复患者再干预风险更高。
  • 当解剖风险因素排除双心室修复时,Fontan术式是可行选择。

研究设计与样本

  • 回顾性分析1990至2015年间澳大利亚129例患者,其中d型大动脉转位/室间隔缺损/左室流出道梗阻85例,l型44例,均具有2个功能心室。
  • 患者接受初次手术治疗,Fontan组29例,双心室修复组100例。
  • 中位手术年龄2.9岁(范围0.2-26.8岁),中位随访6.2年(范围2天至25.8年)。

主要发现

  • 双心室修复组9例死亡(3例早期,6例晚期);Fontan组1例在术后1.2年接受移植。
  • 总体无移植生存率1年95%、5年93%、10年92%、15年90%。
  • 总体无再干预生存率1年79%、5年64%、10年45%、15年29%。
  • 73%的无移植生存者纽约心脏协会(NYHA)心功能分级为I级,Fontan组与双心室组功能状态相似。

临床怎么用

  • 对于d型或l型大动脉转位合并室间隔缺损及左室流出道梗阻、具有双功能心室的患者,Fontan和双心室修复均可考虑。
  • 双心室修复后需关注再干预风险,加强随访。
  • 当解剖风险因素不适合双心室修复时,可选择Fontan术式。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: D-transposition of the great arteries and l-transposition of the great arteries with ventricular septal defect and left ventricular outflow tract obstruction are complex biventricular congenital heart diseases for which decision-making regarding surgical strategy remains challenging. We investigated the intermediate-term outcomes of Fontan versus biventricular procedures in these patients. METHODS: We analyzed 129 patients with d-transposition of the great arteries/ventricular septal defect/left ventricular outflow tract obstruction (n = 85) or l-transposition of the great arteries/ventricular septal defect/left ventricular outflow tract obstruction (n = 44) and 2 functional ventricles from Australia who had primary surgical management (29 Fontan, 100 biventricular repair) undertaken between 1990 and 2015. RESULTS: Median operative age of patients was 2.9 years (range, 0.2-26.8 years). During a median follow-up of 6.2 years (range, 2 days to 25.8 years), 9 patients died after biventricular repair (3 early and 6 late deaths). One patient received a transplant 1.2 years after Fontan completion. Overall transplant-free survivals at 1, 5, 10, and 15 years were 95%, 93%, 92%, and 90%, respectively. Overall reintervention-free survivals at 1, 5, 10, and 15 years were 79%, 64%, 45%, and 29% respectively. Biventricular repair tended to be associated with a higher rate of death, transplantation, or reintervention than the Fontan pathway (hazard ratio, 1.83; 95% confidence interval, 0.90-3.71; P = .10). Some 73% of transplant-free survivors had New York Heart Association class I. Functional status was similar between the Fontan and biventricular groups. CONCLUSIONS: Intermediate-term outcomes were comparable between patients with d-transposition of the great arteries/ventricular septal defect/left ventricular outflow tract obstruction and patients with l-transposition of the great arteries/ventricular septal defect/left ventricular outflow tract obstruction. Both Fontan and biventricular pathways are associated with excellent mortality and functional outcomes. Biventricular patients have a greater risk of reintervention. The Fontan procedure is a viable option when anatomic risk factors preclude biventricular repair.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Sun J, Brizard C, Winlaw D, et al. Biventricular repair versus Fontan completion for patients with d- or l-transposition of the great arteries with ventricular septal defect and left ventricular outflow tract obstruction. J Thorac Cardiovasc Surg. 2019. PMID: 31301903. doi:10.1016/j.jtcvs.2019.05.061

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。